GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Sudarshan Pharma Industries Ltd (BOM:543828) » Definitions » EPS (Basic)

Sudarshan Pharma Industries (BOM:543828) EPS (Basic) : ₹0.66 (TTM As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Sudarshan Pharma Industries EPS (Basic)?

Sudarshan Pharma Industries's basic earnings per share (Basic EPS) for the six months ended in Mar. 2025 was ₹0.41. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0.66.

Sudarshan Pharma Industries's EPS (Diluted) for the six months ended in Mar. 2025 was ₹0.41. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0.66.

Sudarshan Pharma Industries's EPS without NRI for the six months ended in Mar. 2025 was ₹0.46. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was 0.75.

During the past 12 months, Sudarshan Pharma Industries's average EPS without NRIGrowth Rate was 58.70% per year. During the past 3 years, the average EPS without NRI Growth Rate was 10.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was 58.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 9 years, Sudarshan Pharma Industries's highest 3-Year average EPS without NRI Growth Rate was 100.20% per year. The lowest was 10.80% per year. And the median was 53.30% per year.


Sudarshan Pharma Industries EPS (Basic) Historical Data

The historical data trend for Sudarshan Pharma Industries's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sudarshan Pharma Industries EPS (Basic) Chart

Sudarshan Pharma Industries Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only 0.11 0.55 0.55 0.48 0.66

Sudarshan Pharma Industries Semi-Annual Data
Mar17 Mar18 Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.20 0.28 0.25 0.41

Sudarshan Pharma Industries EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Sudarshan Pharma Industries's Basic EPS for the fiscal year that ended in Mar. 2025 is calculated as

Basic EPS (A: Mar. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(159.552-0)/241.745
=0.66

Sudarshan Pharma Industries's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(100.319-0)/242.706
=0.41

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹0.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sudarshan Pharma Industries  (BOM:543828) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Sudarshan Pharma Industries EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Sudarshan Pharma Industries's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Sudarshan Pharma Industries Business Description

Traded in Other Exchanges
N/A
Address
S V Road, 301, 3rd Floor, Aura Biplex, Above Kalyan Jewellers, Borivali (West), Mumbai, MH, IND, 400092
Sudarshan Pharma Industries Ltd is engaged in business in Pharmaceutical formulation & Chemical - Bulk drugs, API, Specialty chemicals, and Solvents in India and abroad.

Sudarshan Pharma Industries Headlines

No Headlines